PPARA and renal cell carcinoma: In the present study we show for the first time that PPARα antagonism attenuates RCC cell growth through G0/G1 phase cell cycle arrest and the induction of apoptosis associated with decreased CDK4, cyclin D1, and c-Myc levels.